3266 Participants Needed

Radial vs. Femoral Access for Cardiac Catheterization Complications

(REBIRTH Trial)

Recruiting at 5 trial locations
BR
OM
Overseen ByOlga Mastrodemos
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Minneapolis Heart Institute Foundation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two methods for inserting a tube into heart blood vessels in patients needing heart checks. One method uses the wrist, and the other uses the groin. The goal is to find out which method is better.

Will I have to stop taking my current medications?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking oral factor Xa or IIa inhibitors, you should not have taken them within 24 hours before the procedure.

Is radial or femoral access for cardiac catheterization generally safe?

Radial access for cardiac catheterization is generally considered safer than femoral access, with fewer and less severe complications. However, radial artery occlusion and rare complications like pseudoaneurysms can occur. Femoral access, while necessary for some procedures, may have more vascular complications, but using ultrasound guidance can help reduce these risks.12345

How does radial access for cardiac catheterization differ from femoral access?

Radial access for cardiac catheterization is unique because it generally results in fewer bleeding complications compared to the traditional femoral access, although it may have a higher rate of access site failure. This approach is considered safer for patients at risk of femoral complications, and ongoing improvements in the technique are expected to enhance outcomes further.24678

What data supports the effectiveness of the treatment Radial Access, State-of-the-art femoral access with 18 gauge needle, and State-of-the-art femoral access with 21 gauge needle for cardiac catheterization complications?

Research shows that radial access is generally safer than femoral access in terms of vascular complications during cardiac procedures. Additionally, using ultrasound guidance during femoral access can reduce the risk of complications, making it a safer option for high-risk procedures.12459

Who Is on the Research Team?

EB

Emmanouil Brilakis, MD, PhD

Principal Investigator

Minneapolis Heart Institute Foundation

Are You a Good Fit for This Trial?

Adults over 18 eligible for cardiac catheterization via both radial and femoral access, who consent to participate. Suitable for those needing diagnostic angiography or urgent/elective PCI, but not for patients with recent oral anticoagulant use, peripheral arterial disease affecting access sites, limited life expectancy, certain heart conditions or procedures within the next month.

Inclusion Criteria

Has provided informed consent and agrees to participate
I am scheduled for a heart artery exam due to chest pain, possibly with treatment.
I can have a heart catheterization through my wrist or groin.

Exclusion Criteria

I took blood thinners less than 24 hours before the procedure.
I have a dialysis access point in my arm that can be used for a heart procedure.
Coexisting conditions that limit life expectancy to less than 30 days
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cardiac catheterization using either radial or state-of-the-art femoral access

During procedure
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the procedure, including evaluations of myocardial infarction and procedural success

4 weeks
Evaluations up to 30 days

What Are the Treatments Tested in This Trial?

Interventions

  • Radial Access
  • State-of-the-art femoral access with 18 gauge needle
  • State-of-the-art femoral access with 21 gauge needle
Trial Overview This phase IV trial compares two methods of accessing the heart during catheterization: through the wrist (radial access) and upper thigh (femoral access). Participants are randomly assigned to one method; those in the femoral group are further randomized to receive either a smaller (21 gauge) or larger (18 gauge) needle.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: State-of-the-art femoral accessActive Control2 Interventions
Group II: Radial accessActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Minneapolis Heart Institute Foundation

Lead Sponsor

Trials
32
Recruited
15,700+

Published Research Related to This Trial

In a study of 56 patients on uninterrupted warfarin therapy, radial access for cardiac catheterization was found to be as effective as femoral access, with procedural success achieved in all femoral patients and only one crossover in the radial group.
Radial access significantly reduced access-site complications during percutaneous coronary intervention (PCI), with 37.5% of femoral patients experiencing complications compared to none in the radial group, highlighting its safety advantage.
Radial versus femoral access for orally anticoagulated patients.Ziakas, AG., Koskinas, KC., Gavrilidis, S., et al.[2014]
In a study of 8404 patients with acute coronary syndrome, using radial access for coronary procedures resulted in fewer net adverse clinical events compared to femoral access, particularly reducing major bleeding and all-cause mortality.
Radial access was associated with a lower rate of major adverse cardiovascular events (8.8% vs. 10.3% for femoral access), although this difference was not statistically significant at the stricter alpha level of 0.025.
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.Valgimigli, M., Gagnor, A., Calabró, P., et al.[2023]
Using ultrasound guidance during femoral artery catheterization significantly reduces the risk of vascular-access related complications, with a complication rate of 1.9% compared to 4.3% without ultrasound, based on a systematic review of 5 randomized-controlled trials involving 1553 patients.
The reduction in complications is mainly due to fewer local hematomas; however, when excluding hematomas, the significance of the results diminishes, indicating that further research is needed to fully understand the impact of ultrasound on major bleeding and other vascular complications.
Ultrasound Guidance in Femoral Artery Catheterization: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials.Rashid, MK., Sahami, N., Singh, K., et al.[2020]

Citations

Radial versus femoral access for orally anticoagulated patients. [2014]
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. [2023]
Ultrasound Guidance in Femoral Artery Catheterization: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials. [2020]
Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry. [2021]
Radial artery pseudoaneurysm following coronary angiography in two octogenarians. [2021]
Is radial artery occlusion and local vascular complications following transradial coronary procedures affected by the type of haemostasis device used? A non-inferiority Randomized Controlled Trial (RadCom trial). [2022]
[Vascular complications associated with radial artery access for cardiac catheterization]. [2012]
Vascular Complications of Percutaneous Transradial Cardiac Catheterization. [2022]
Sirens song or a bugle call to charge. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security